BYDUREON BCISE 2 mg was statistically superior to placebo (ANCOVA p-value=0.02)
July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)
In a psoriasis-like skin model induced with imiquimod in obese diabetic mice, treatment with liraglutide has been demonstrated to decrease psoriasis clinical scores and downregulate major inflammatory cytokines, which include IL-17, IL-22, IL-23 and TNF- [205]
GLP-1 receptor agonists slow gastric emptying significantly
The downfall of Retinyl Palmitate was due to released reports about the ingredient being correlated to sun damage and skin tumors
'Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54.' Proceedings of the National Academy of Sciences
